Literature DB >> 2765566

Human neutrophils contain distinct cytosolic and particulate tyrosine kinase activities: possible role in neutrophil activation.

R L Berkow1, R W Dodson, A S Kraft.   

Abstract

Tyrosine protein kinase activities were partially purified from circulating human neutrophils. Purification steps involved sequential chromatography on DEAE-Sephacel, gel filtration and affinity chromatography on a column composed of a glutamine:tyrosine copolymer linked to AH-Sepharose. The results indicate that human neutrophils contain a tyrosine kinase activity in the 150,000 x g cytosolic fraction which is distinct from the activity in a detergent extractable 150,000 x g particulate fraction. These enzyme activities are dependent on the divalent cations Mn2+ and Mg2+. Kinetics for the phosphorylation of a glutamine:tyrosine copolymer substrate demonstrated an apparent Km for the cytosolic tyrosine kinase activity of 22.3 +/- 0.3 microM, and an apparent Km for the particulate extract activity of 42.7 +/- 6.0 microM. By gel filtration chromatography, the cytosolic and particulate tyrosine kinase activities have approximate molecular masses of 80-90 and 50-60 kDa, respectively. The particulate but not the cytosolic neutrophil tyrosine kinase activity was inhibited by a novel tyrosine kinase inhibitor ST638. ST638 inhibited superoxide production in intact neutrophils stimulated with the chemotactic peptide F-Met-Leu-Phe, opsonized zymosan particles, and sodium fluoride. ST638 did not, however, inhibit superoxide production in neutrophils stimulated with phorbol myristate acetate or the calcium ionophore, A23187.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765566     DOI: 10.1016/0167-4838(89)90200-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells.

Authors:  S Offermanns; R Seifert; J W Metzger; G Jung; A Lieberknecht; U Schmidt; G Schultz
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Protein tyrosine phosphorylation in rabbit peritoneal neutrophils.

Authors:  C K Huang; V Bonak; G R Laramee; J E Casnellie
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

3.  Activation of permeabilized HL60 cells by vanadate. Evidence for divergent signalling pathways.

Authors:  S Trudel; G P Downey; S Grinstein; M R Pâquet
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

4.  Mechanism of vanadate-induced activation of tyrosine phosphorylation and of the respiratory burst in HL60 cells. Role of reduced oxygen metabolites.

Authors:  S Trudel; M R Pâquet; S Grinstein
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

5.  Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner.

Authors:  W R Huckle; C A Prokop; R C Dy; B Herman; S Earp
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate.

Authors:  U Zor; E Ferber; P Gergely; K Szücs; V Dombrádi; R Goldman
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

7.  Selective inhibition of PGE2 production in cells transfected with c-fms encoded CSF-1 receptor genes by the tyrosine kinase inhibitor, ST638.

Authors:  J Puri; J H Pierce; T Hoffman
Journal:  Agents Actions       Date:  1991-07

8.  Tyrosine phosphorylation and activation of NADPH oxidase in human neutrophils: a possible role for MAP kinases and for a 75 kDa protein.

Authors:  S Dusi; M Donini; F Rossi
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

9.  Zymosan-triggered tyrosine phosphorylation in mouse bone-marrow-derived macrophages is enhanced by respiratory-burst priming agents.

Authors:  S P Green; J A Hamilton; W A Phillips
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

10.  Inhibition of human neutrophil responses by alpha-cyano-3,4-dihydroxythiocinnamamide; a protein-tyrosine kinase inhibitor.

Authors:  P Dryden; V Duronio; L Martin; A T Hudson; H Salari
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.